DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,409,000 | -46.8% | 764,310 | -1.5% | 0.00% | -40.0% |
| Q2 2021 | $28,948,000 | +46.8% | 775,659 | +0.5% | 0.01% | +25.0% |
| Q1 2021 | $19,726,000 | +7.4% | 771,469 | -7.5% | 0.00% | 0.0% |
| Q4 2020 | $18,372,000 | +20.2% | 833,896 | -1.9% | 0.00% | +33.3% |
| Q3 2020 | $15,288,000 | -32.0% | 849,862 | -3.9% | 0.00% | -40.0% |
| Q2 2020 | $22,470,000 | +70.0% | 884,606 | +22.9% | 0.01% | +25.0% |
| Q1 2020 | $13,219,000 | -12.7% | 719,593 | +4.7% | 0.00% | +33.3% |
| Q4 2019 | $15,139,000 | +53.4% | 687,251 | -0.0% | 0.00% | +50.0% |
| Q3 2019 | $9,872,000 | -8.3% | 687,442 | +0.5% | 0.00% | -33.3% |
| Q2 2019 | $10,768,000 | +11.5% | 683,682 | +3.7% | 0.00% | +50.0% |
| Q1 2019 | $9,659,000 | +39.6% | 659,334 | +1.9% | 0.00% | 0.0% |
| Q4 2018 | $6,917,000 | -18.9% | 647,143 | +15.9% | 0.00% | 0.0% |
| Q3 2018 | $8,524,000 | +43.0% | 558,584 | +14.8% | 0.00% | 0.0% |
| Q2 2018 | $5,962,000 | +949.6% | 486,668 | +719.5% | 0.00% | – |
| Q1 2018 | $568,000 | +73.7% | 59,384 | +63.7% | 0.00% | – |
| Q4 2017 | $327,000 | +58.0% | 36,282 | +0.8% | 0.00% | – |
| Q3 2017 | $207,000 | +81.6% | 36,010 | -0.6% | 0.00% | – |
| Q2 2017 | $114,000 | -1.7% | 36,219 | +6.1% | 0.00% | – |
| Q1 2017 | $116,000 | +23.4% | 34,125 | +3.9% | 0.00% | – |
| Q4 2016 | $94,000 | -63.4% | 32,851 | -24.7% | 0.00% | – |
| Q3 2016 | $257,000 | +135.8% | 43,612 | +19.6% | 0.00% | – |
| Q2 2016 | $109,000 | -88.5% | 36,463 | -79.4% | 0.00% | – |
| Q1 2016 | $946,000 | -53.2% | 176,645 | +3.6% | 0.00% | -100.0% |
| Q4 2015 | $2,023,000 | +44.3% | 170,468 | -0.2% | 0.00% | – |
| Q3 2015 | $1,402,000 | +37.7% | 170,759 | +134.0% | 0.00% | – |
| Q2 2015 | $1,018,000 | -19.8% | 72,980 | +38.1% | 0.00% | – |
| Q1 2015 | $1,270,000 | +58.9% | 52,837 | +8.9% | 0.00% | – |
| Q4 2014 | $799,000 | +35.4% | 48,505 | +4.7% | 0.00% | – |
| Q3 2014 | $590,000 | -37.3% | 46,308 | +11.1% | 0.00% | – |
| Q2 2014 | $941,000 | +68.9% | 41,690 | +111.4% | 0.00% | – |
| Q1 2014 | $557,000 | – | 19,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|